ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $14 | +16.7% | 3,792 | 0.0% | 0.00% | – |
| Q1 2024 | $12 | -83.1% | 3,792 | -73.7% | 0.00% | -100.0% |
| Q4 2023 | $71 | -16.5% | 14,396 | -7.3% | 0.00% | 0.0% |
| Q3 2023 | $85 | -18.3% | 15,525 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $104 | +1.0% | 15,525 | +33.4% | 0.00% | 0.0% |
| Q1 2023 | $103 | -7.2% | 11,642 | -19.9% | 0.00% | 0.0% |
| Q4 2022 | $111 | -99.9% | 14,533 | +2.3% | 0.00% | 0.0% |
| Q3 2022 | $101,000 | -12.2% | 14,213 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $115,000 | -66.8% | 14,199 | -43.0% | 0.00% | -66.7% |
| Q1 2022 | $346,000 | -72.8% | 24,913 | -45.0% | 0.00% | -40.0% |
| Q4 2021 | $1,270,000 | +89.8% | 45,256 | +129.9% | 0.01% | -16.7% |
| Q3 2021 | $669,000 | -21.7% | 19,684 | -5.8% | 0.01% | -14.3% |
| Q2 2021 | $854,000 | +49.6% | 20,896 | +47.4% | 0.01% | -66.7% |
| Q1 2021 | $571,000 | -37.4% | 14,180 | -8.0% | 0.02% | -40.0% |
| Q4 2020 | $912,000 | +21.6% | 15,418 | -0.0% | 0.04% | +6.1% |
| Q3 2020 | $750,000 | +5.0% | 15,424 | +4.5% | 0.03% | 0.0% |
| Q2 2020 | $714,000 | +57.6% | 14,753 | -9.6% | 0.03% | +200.0% |
| Q1 2020 | $453,000 | – | 16,311 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,687,665 | $5,417,405 | 5.10% |
| Rubric Capital Management LP | 10,500,000 | $33,705,000 | 1.00% |
| Triatomic Management LP | 98,555 | $316,362 | 0.59% |
| Pier Capital, LLC | 1,103,441 | $3,542,046 | 0.49% |
| Newtyn Management, LLC | 623,690 | $2,002,045 | 0.40% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $96,279,803 | 0.36% |
| Matrix Capital Management Company, LP | 11,572,590 | $37,148,014 | 0.34% |
| Tejara Capital Ltd | 269,014 | $863,535 | 0.32% |
| Aristotle Atlantic Partners, LLC | 2,992,563 | $9,606,127 | 0.31% |
| DDD Partners, LLC | 739,739 | $2,374,562 | 0.29% |